Fifty 1 Labs, Inc. (FITY)
Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic
Fifty 1 Labs, Inc. (FITY) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $114.38K. Trailing PE -0.96. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 4 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signup1-Year Price
Proprietary Signals
About Fifty 1 Labs, Inc.
Fifty 1 Labs, Inc. is a Nevada-based holding company that has shifted its focus to biotechnology and telehealth, centering on peptide science for musculoskeletal health, recovery, and performance. The company utilizes AI-driven research and aims to develop a telehealth platform for personalized peptide therapies. Formerly involved in automotive finance, the company is now pursuing growth in the functional medicine and life sciences sectors.
Valuation
| P/E (TTM) | -0.96× |
|---|---|
| P/S (TTM) | 2433.53× |
| P/B | -0.30× |
| P/FCF (TTM) | -1.80× |
| EV / EBITDA | -1.65× |
| EV / Sales | 5912.02× |
| Earnings Yield | -104.09% |
| Free Cash Flow Yield | -55.62% |
Fundamentals
| Enterprise Value | $277.87K |
|---|---|
| Revenue (TTM) | $47.00 |
| Net Income (TTM) | -$119.05K |
| Free Cash Flow (TTM) | $13.84K |
| Net Debt | $163.49K |
| Working Capital | -$627.24K |
| Gross Margin | 0.00% |
| Operating Margin | -358397.87% |
| Net Margin | -523204.26% |
| Return on Equity | 72.68% |
| Return on Invested Capital | 26.86% |
Peers
Recent News
Related
Browse more tickers: sitemap